131 
MR. HUTT: It is spelled out that it will be given to other laborato- 
ries for verification. 
DR. FREDRICKSON: Perhaps someone could identify the page and help us 
with the exact question. 
MR. HUTT: I could not find that procedure spelled out, Dr. Berg. 
DR. FREDRICKSON: Dr. Rowe, you had a point. You are a member of the 
committee, the NIH committee. 
DR. ROWE: I want to just comment on a couple of aspects of it. I 
heard what you said, but I think the point between the technical committee 
and the policy committee is the difference between our DNA program advisory 
committee and this whole committee today. You are the policy committee, 
to decide on the broad base, the public interest basis of whether what we 
did technically is then adequate protection for the public. I think that 
structure is already there and that is why you are here today. 
On the other thing of going ahead, and the question of whether the 
committee should have considered going slower, and so on, as a person who 
took a very conservative, that is a very restrictive position on the com- 
mittee. I think we are in the very safe position in that what I think we 
did was a very great overkill in that we have built in conservatism on top 
of conservatism, and I think we have done a very good job of restraining 
or writing guidelines that are very restraining in relation to what will 
eventually be seen as the real magnitude of risks. I think we are not 
subject to accusations of having been cavalier at all in setting this 
thing up. I think we have really overkilled in the other direction, and 
have done a very safe job. 
DR. WRIGHT: My comments were meant to apply in general rather than to 
the particular committee, except as far as the composition is concerned. 
So I am not sure that what you say answers really the point that the com- 
mittee operated under the presumption that the research was acceptable. 
In my view it would have been preferable had a first committee advised 
simply on the nature of the risks and how to contain it instead of — and 
then a second committee would then advise on whether that would be accept- 
able. As I see it, that distinction was not clearly drawn. 
DR. FREDRICKSON: Our time is running a bit short, but I will recog- 
nize first Mr. Hutt and then Dr. Koshland, and then Mr. Ladwig. 
MR. HUTT: The only sentence that I have been able to find is the first 
sentence on page 18, and Dr. Singer, I would hope you would correct me, but 
it says "EK2 host-vectors - These are host-vector systems that have been 
[272] 
